Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mettrum Health was a leading Canadian producer and vendor of medical cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The company was known for its proprietary "Mettrum Spectrum" system, which categorized medical cannabis products by color to simplify the selection process for physicians and patients based on THC and CBD levels. Mettrum operated multiple licensed production facilities in Ontario and was one of the first companies to receive a license from Health Canada. In January 2017, the company was acquired by Canopy Growth Corporation in an all-stock deal, significantly expanding Canopy's market share and production capacity. Following the acquisition, Mettrum's operations were integrated into the Canopy Growth brand portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mettrum Health.